4.6 Article

Certified causes of death in patients with mesothelioma in South East England

Journal

BMC CANCER
Volume 9, Issue -, Pages -

Publisher

BIOMED CENTRAL LTD
DOI: 10.1186/1471-2407-9-28

Keywords

-

Categories

Ask authors/readers for more resources

Background: Mesothelioma is a highly fatal cancer that is caused by exposure to asbestos fibres. In many populations, the occurrence of mesothelioma is monitored with the use of mortality data from death certification. We examine certified causes of death of patients who have been diagnosed with mesothelioma, and assess the validity of death certification data as a proxy for mesothelioma incidence. Methods: We extracted mesothelioma registrations in the South East of England area between 2000 and 2004 from the Thames Cancer Registry database. We retained for analysis 2200 patients who had died at the time of analysis, after having excluded seven dead cases where the causes of death were not known to the cancer registry. The 2200 deaths were classified hierarchically to identify (1) mesothelioma deaths, (2) deaths certified as lung cancer deaths or (3) deaths from unspecified cancer, and (4) deaths from other causes. Results: 87% of the patients had mesothelioma mentioned on the death certificate. 6% had no mention of mesothelioma but included lung cancer as a cause of death. Another 6% had no mention of mesothelioma or lung cancer, but included an unspecified cancer as a cause of death. Lastly, 2% had other causes of death specified on the death certificate. Conclusion: This analysis suggests that official mortality data may underestimate the true occurrence of mesothelioma by around 10%.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Primary Health Care

Association between GPs' suspicion of cancer and patients' usual consultation pattern in primary care: a cross-sectional study

Henry Jensen, Camilla Hoffmann Merrild, Henrik Moller, Peter Vedsted

BRITISH JOURNAL OF GENERAL PRACTICE (2019)

Article Oncology

Serum glucose, triglycerides, and cholesterol in relation to prostate cancer death in the Swedish AMORIS study

Rhonda Arthur, Henrik Moller, Hans Garmo, Christel Haggstrom, Lars Holmberg, Par Stattin, Hakan Malmstrom, Mats Lambe, Niklas Hammar, Goran Walldius, David Robinson, Ingmar Jungner, Mieke Van Hemelrijck

CANCER CAUSES & CONTROL (2019)

Letter Radiology, Nuclear Medicine & Medical Imaging

Is there an optimal method for measuring baseline metabolic tumor volume in diffuse large B cell lymphoma?

Hajira Ilyas, N. George Mikhaeel, Joel T. Dunn, Fareen Rahman, Henrik Moller, Daniel Smith, Sally F. Barrington

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)

Article Medicine, General & Internal

ETS-related gene (ERG) expression as a predictor of oncological outcomes in patients with high-grade prostate cancer treated with primary androgen deprivation therapy: a cohort study

Mark Rezk, Ashish Chandra, Daniel Addis, Henrik Moller, Mina Youssef, Prokar Dasgupta, Hide Yamamoto

BMJ OPEN (2019)

Article Oncology

Long-term Somatic Disease Risk in Adult Danish Cancer Survivors

Trille Kristina Kjaer, Elisabeth Anne Wreford Andersen, Jeanette Falck Winther, Pernille Envold Bidstrup, Michael Borre, Henrik Moller, Signe Benzon Larsen, Christoffer Johansen, Susanne Oksbjerg Dalton

JAMA ONCOLOGY (2019)

Article Oncology

Cancer diagnostic delays and travel distance to health services: A nationwide cohort study in Denmark

Line Flytkjaer Virgilsen, Henrik Moller, Peter Vedsted

CANCER EPIDEMIOLOGY (2019)

Article Oncology

Causes of death in men with prostate cancer: Results from the Danish Prostate Cancer Registry (DAPROCAdata)

Mary Nguyen-Nielsen, Henrik Moller, Anne Tjonneland, Michael Borre

CANCER EPIDEMIOLOGY (2019)

Article Cell Biology

The percentage of high-grade prostatic adenocarcinoma in prostate biopsies significantly improves on Grade Groups in the prediction of prostate cancer death

Daniel M. Berney, Luis Beltran, Holly Sandu, Geraldine Soosay, Henrik Moller, Peter Scardino, Jacqueline Murphy, Amar Ahmad, Jack Cuzick

HISTOPATHOLOGY (2019)

Article Pathology

Ki-67 is an independent predictor of prostate cancer death in routine needle biopsy samples: proving utility for routine assessments

Solene-Florence Kammerer-Jacquet, Amar Ahmad, Henrik Moller, Holly Sandu, Peter Scardino, Geraldine Soosay, Luis Beltran, Jack Cuzick, Daniel M. Berney

MODERN PATHOLOGY (2019)

Article Public, Environmental & Occupational Health

Travel distance to cancer-diagnostic facilities and tumour stage

Line Flytkjaer Virgilsen, Henrik Moller, Peter Vedsted

HEALTH & PLACE (2019)

Article Primary Health Care

Association between use of urgent suspected cancer referral and mortality and stage a diagnosis: a 5-year national cohort study

Thomas Round, Carolynn Gildea, Mark Ashworth, Henrik Moller

BRITISH JOURNAL OF GENERAL PRACTICE (2020)

Article Medicine, General & Internal

Yorkshire Lung Screening Trial (YLST): protocol for a randomised controlled trial to evaluate invitation to community-based low-dose CT screening for lung cancer versus usual care in a targeted population at risk

Philip A. J. Crosbie, Rhian Gabe, Irene Simmonds, Martyn Kennedy, Suzanne Rogerson, Nazia Ahmed, David R. Baldwin, Richard Booton, Ann Cochrane, Michael Darby, Kevin Franks, Sebastian Hinde, Sam M. Janes, Una Macleod, Mike Messenger, Henrik Moller, Rachael L. Murray, Richard D. Neal, Samantha L. Quaife, Mark Sculpher, Puvanendran Tharmanathan, David Torgerson, Matthew E. J. Callister

BMJ OPEN (2020)

Article Oncology

The incidence of major subtypes of primary brain tumors in adults in England 1995-2017

Hiba A. Wanis, Henrik Moller, Keyoumars Ashkan, Elizabeth A. Davies

Summary: This study described the incidence of adult primary brain tumors by major subtypes in England using data from the National Cancer Registration and Analysis Service (NCRAS). Glioblastoma was the most frequent tumor subtype, followed by meningioma. The increase in the incidence of major subtypes of brain tumors in England could be explained by advances in clinical practice.

NEURO-ONCOLOGY (2021)

Article Oncology

The Influence of Ethnicity on Survival from Malignant Primary Brain Tumours in England: A Population-Based Cohort Study

Hiba A. Wanis, Henrik Moller, Keyoumars Ashkan, Elizabeth A. Davies

Summary: This study found ethnic differences in survival rates of patients with malignant primary brain tumors in England. Patients with an Indian background, Any Other White, Other Ethnic Group, and Unknown/Not Stated Ethnicity had better one-year survival rates than the White British Group, after adjusting for known prognostic factors. Understanding these ethnic variations could help identify potential risk or protective factors and improve patient outcomes.

CANCERS (2023)

Article Medicine, General & Internal

Regional and socio-economic variation in survival after a pancreatic cancer diagnosis in Denmark

Henriette Engberg, Marianne Steding-Jessen, Inge Oster, Jens Winther Jensen, Claus Wilki Fristrup, Henrik Moller

DANISH MEDICAL JOURNAL (2020)

No Data Available